Evidence map›Paper›PMID 30085889›Full record

ArticleJournal of global oncology2018

Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies?

Martine Bellanger, Nur Zeinomar, Parisa Tehranifar, Mary Beth Terry

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Martine BellangerMartine Bellanger, Ecole des Hautes Etudes en Sante Publique - University Sorbonne Paris Cite, Paris, France; Nur Zeinomar, Prisa Tehranifar, and Mary Beth Terry, Columbia University; Parisa Tehranifar and Mary Beth Terry, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY; and Martine Bellanger, Nur Zeinomar, Parisa Tehranifar, and Mary Beth Terry, International Breast Cancer and Nutrition Project, Lafayette, IN.
Nur ZeinomarMartine Bellanger, Ecole des Hautes Etudes en Sante Publique - University Sorbonne Paris Cite, Paris, France; Nur Zeinomar, Prisa Tehranifar, and Mary Beth Terry, Columbia University; Parisa Tehranifar and Mary Beth Terry, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY; and Martine Bellanger, Nur Zeinomar, Parisa Tehranifar, and Mary Beth Terry, International Breast Cancer and Nutrition Project, Lafayette, IN.
Parisa TehranifarMartine Bellanger, Ecole des Hautes Etudes en Sante Publique - University Sorbonne Paris Cite, Paris, France; Nur Zeinomar, Prisa Tehranifar, and Mary Beth Terry, Columbia University; Parisa Tehranifar and Mary Beth Terry, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY; and Martine Bellanger, Nur Zeinomar, Parisa Tehranifar, and Mary Beth Terry, International Breast Cancer and Nutrition Project, Lafayette, IN.
Mary Beth TerryMartine Bellanger, Ecole des Hautes Etudes en Sante Publique - University Sorbonne Paris Cite, Paris, France; Nur Zeinomar, Prisa Tehranifar, and Mary Beth Terry, Columbia University; Parisa Tehranifar and Mary Beth Terry, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY; and Martine Bellanger, Nur Zeinomar, Parisa Tehranifar, and Mary Beth Terry, International Breast Cancer and Nutrition Project, Lafayette, IN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose There remains considerable international variation in breast cancer incidence and mortality, but a comprehensive examination of rates by country level economic, development and cancer prevention policies is lacking. Materials and Methods We compared GLOBOCAN 2012 age-specific breast cancer incidence and mortality rates for 177 countries by using development and policy data available from the WHO Global Cancer Country Profiles data base. We classified each country on the basis of gross national income per capita from the World Development Indicators data base, as follows: low-income country (LIC), lower-middle-income country (LMIC), upper-middle-income country (UMIC), and high-income country (HIC). Results There were 1,651,326 breast cancer cases and 516,868 breast cancer deaths estimated in 2012. Approximately three quarters of all breast cancer cases and 60% of the breast cancer deaths were in women from HICs and UMICs. Age and country-level income explained approximately 60% of the international variation in breast cancer incidence and mortality in women of all ages (adjusted R

Indexed as

AdultBreast NeoplasmsEconomic DevelopmentFemaleGlobal HealthHumansIncidenceMiddle AgedMortalityPreventive Medicine

Identifiers

PMID30085889
PMCPMC6223528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.